These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 16247444

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Loss of p53 in craf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch.
    Fedorov LM, Papadopoulos T, Tyrsin OY, Twardzik T, Götz R, Rapp UR.
    Cancer Res; 2003 May 01; 63(9):2268-77. PubMed ID: 12727849
    [Abstract] [Full Text] [Related]

  • 23. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S, Kang J, Cho M, Seo E, Choi H, Kim E, Kim J, Kim H, Kang GY, Kim KP, Park YH, Yu DY, Yum YN, Park SN, Yoon DY.
    Int J Oncol; 2009 Jan 01; 34(1):161-72. PubMed ID: 19082487
    [Abstract] [Full Text] [Related]

  • 24. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model.
    Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM.
    Oncogene; 2000 Nov 09; 19(47):5338-47. PubMed ID: 11103935
    [Abstract] [Full Text] [Related]

  • 25. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
    Hong HH, Dunnick J, Herbert R, Devereux TR, Kim Y, Sills RC.
    Environ Mol Mutagen; 2007 Nov 09; 48(3-4):299-306. PubMed ID: 16395694
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Mouse models of K-ras-initiated oncogenesis].
    Barrière C, Marjou FE, Louvard D, Robine S.
    Bull Cancer; 2009 Dec 09; 96 Suppl():S5-14. PubMed ID: 20034865
    [Abstract] [Full Text] [Related]

  • 31. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.
    Karasaki H, Obata M, Ogawa K, Lee GH.
    Oncogene; 1997 Oct 09; 15(15):1833-40. PubMed ID: 9362450
    [Abstract] [Full Text] [Related]

  • 32. p53 and K-ras in radon-associated lung adenocarcinoma.
    McDonald JW, Taylor JA, Watson MA, Saccomanno G, Devereux TR.
    Cancer Epidemiol Biomarkers Prev; 1995 Oct 09; 4(7):791-3. PubMed ID: 8672998
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea.
    Zhou H, Liu L, Lee K, Qin X, Grasso AW, Kung HJ, Willis JE, Kern J, Wagner T, Gerson SL.
    Oncogene; 2002 Dec 12; 21(57):8732-40. PubMed ID: 12483526
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
    Herzog CR, Lubet RA, You M.
    J Cell Biochem Suppl; 1997 Dec 12; 28-29():49-63. PubMed ID: 9589349
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.